Ohr Pharmaceutical (OHRP) And Cold Spring Harbor Laboratory Announce Joint Venture To Develop Trodusquemine And Related Analogs
3/3/2014 8:31:56 AM
NEW YORK--(BUSINESS WIRE)--Ohr Pharmaceutical (NasdaqCM:OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, and leading global cancer research center Cold Spring Harbor Laboratory (CSHL) today announced the establishment of DepYmed Inc., a new joint venture to develop trodusquemine and related analogs.
Help employers find you! Check out all the jobs and post your resume.